我們已在上線! 進一步了解
WWB

Windward Bio Group

27.94 USD
-0.56
1.96%
收盤時 已更新 11月16日 上午11:36 EST
1天
-1.96%
5天
52.26%
1個月
-1.96%
3個月
-1.96%
6個月
-1.96%
今年迄今
-1.96%
1年
-1.96%
5年
-1.96%
10年
-1.96%
 

關於: Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. Its flagship program is WIN378, a potentially novel, long-acting, anti-TSLP monoclonal antibody. The pipeline also includes WIN027, a clinical-stage, long-acting anti-TSLPxIL-13 bi-specific, which has therapeutic application across immunological diseases.

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於WWB的最新新聞文章。

價格圖表採用Lightweight Charts™實作